{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:57:51Z","timestamp":1781647071683,"version":"3.54.5"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ketogenic diets are commonly used for epilepsy therapy and are increasingly being considered in cancer treatment, where metabolic reprogramming triggered by glucose restriction and ketosis alters energy provision as the therapeutic mechanism. However, a recently developed medium chain triglyceride product, with a high decanoic acid (DA) to octanoic acid (OA) ratio (DA: OA) has enabled a much less restrictive diet and is clinically effective as an epilepsy treatment, yet no studies have explored the product in cancer models. Here we investigate metabolic mechanisms of DA, OA and DA: OA using a cellular glioblastoma model, focusing on changes in energy metabolism. We show, at a transcriptional level, that DA provides the dominant regulatory influence, enhancing transcription of fatty acid and amino acid metabolism pathways, while reducing cancer-associated glucose metabolism and kinase pathways. DA: OA treatment shared some of these effects, with little influence from OA. At a protein level, DA: OA treatment played the dominant role, regulating metabolic, cancer and signalling pathways, including a large network centred around albumin and protein kinase activities. Finally, at a metabolomic level, both DA and DA: OA treatment reduced vitamin B5 (pantothenate) levels, which is necessary for the synthesis of coenzyme A used in the activation of fatty acids for energy provision, suggesting a novel mechanism to reduce cellular energy provision in cancer. Importantly, these effects occur under high glucose conditions. Thus, we show that decanoic acid-rich treatments may regulate glioblastoma cell biology through targeted effects on glucose and fatty acid metabolism and kinase signalling and may trigger a potential reduction in pantothenate levels in glioblastoma cells, providing a potential novel therapeutic mechanism in cancer treatment.<\/jats:p>","DOI":"10.1186\/s12885-026-15909-3","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:36:12Z","timestamp":1775522172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic targeting of pantothenate by medium chain fats in glioblastoma cells"],"prefix":"10.1186","volume":"26","author":[{"given":"Erwann","family":"Pain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj K","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasin","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Lynham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie Lloyd","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Beesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Gentry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin SB","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"15909_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.molmet.2019.06.026","volume":"33","author":"DD Weber","year":"2020","unstructured":"Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B. Ketogenic diet in the treatment of cancer - Where do we stand? Mol Metab. 2020;33:102\u201321.","journal-title":"Mol Metab"},{"issue":"6","key":"15909_CR2","doi-asserted-by":"publisher","first-page":"e0129802","DOI":"10.1371\/journal.pone.0129802","volume":"10","author":"RJ Morscher","year":"2015","unstructured":"Morscher RJ, Aminzadeh-Gohari S, Feichtinger RG, Mayr JA, Lang R, Neureiter D, et al. Inhibition of neuroblastoma tumor growth by ketogenic diet and\/or calorie restriction in a CD1-Nu mouse model. PLoS ONE. 2015;10(6):e0129802.","journal-title":"PLoS ONE"},{"issue":"Suppl 8","key":"15909_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1528-1167.2008.01821.x","volume":"49","author":"JW Wheless","year":"2008","unstructured":"Wheless JW. History of the ketogenic diet. Epilepsia. 2008;49(Suppl 8):3\u20135.","journal-title":"Epilepsia"},{"key":"15909_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.nutr.26.061505.111258","volume":"26","author":"GF Cahill Jr","year":"2006","unstructured":"Cahill GF Jr. Fuel metabolism in starvation. Annu Rev Nutr. 2006;26:1\u201322.","journal-title":"Annu Rev Nutr"},{"key":"15909_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fnut.2019.00046","volume":"6","author":"V St-Pierre","year":"2019","unstructured":"St-Pierre V, Vandenberghe C, Lowry CM, Fortier M, Castellano CA, Wagner R, et al. Plasma ketone and medium chain fatty acid response in humans consuming different medium chain triglycerides during a metabolic study day. Front Nutr. 2019;6:46.","journal-title":"Front Nutr"},{"issue":"5","key":"15909_CR6","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.1528-1167.2008.01870.x","volume":"50","author":"EG Neal","year":"2009","unstructured":"Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia. 2009;50(5):1109\u201317.","journal-title":"Epilepsia"},{"key":"15909_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12986-016-0113-y","volume":"13","author":"JL Tan-Shalaby","year":"2016","unstructured":"Tan-Shalaby JL, Carrick J, Edinger K, Genovese D, Liman AD, Passero VA, et al. Modified atkins diet in advanced malignancies - final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System. Nutr Metab (Lond). 2016;13:52.","journal-title":"Nutr Metab (Lond)"},{"issue":"2","key":"15909_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1080\/07315724.1995.10718495","volume":"14","author":"LC Nebeling","year":"1995","unstructured":"Nebeling LC, Miraldi F, Shurin SB, Lerner E. Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. J Am Coll Nutr. 1995;14(2):202\u20138.","journal-title":"J Am Coll Nutr"},{"key":"15909_CR9","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3389\/fnins.2020.00783","volume":"14","author":"F Damiano","year":"2020","unstructured":"Damiano F, De Benedetto GE, Longo S, Giannotti L, Fico D, Siculella L, et al. Decanoic acid and not octanoic acid stimulates fatty acid synthesis in U87MG glioblastoma cells: a metabolomics study. Front Neurosci. 2020;14:783.","journal-title":"Front Neurosci"},{"issue":"39","key":"15909_CR10","doi-asserted-by":"publisher","first-page":"64728","DOI":"10.18632\/oncotarget.20041","volume":"8","author":"S Aminzadeh-Gohari","year":"2017","unstructured":"Aminzadeh-Gohari S, Feichtinger RG, Vidali S, Locker F, Rutherford T, O\u2019Donnel M, et al. A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model. Oncotarget. 2017;8(39):64728\u201344.","journal-title":"Oncotarget"},{"key":"15909_CR11","doi-asserted-by":"publisher","unstructured":"Williams RSB, Boison D, Masino SA, Rho JM. Mechanisms of Ketogenic Diet Action. In: Jasper\u2019s Basic Mechanisms of the Epilepsies. 5th ed. Edited by Noebels JL, Avoli M, Rogawski MA, Vezzani A, Delgado-Escueta AV. New York; 2024:1635\u201366. https:\/\/doi.org\/10.1093\/med\/9780197549469.003.0079.","DOI":"10.1093\/med\/9780197549469.003.0079"},{"issue":"1","key":"15909_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1474-4422(17)30408-8","volume":"17","author":"K Augustin","year":"2018","unstructured":"Augustin K, Khabbush A, Williams S, Eaton S, Orford M, Cross JH, et al. Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol. 2018;17(1):84\u201393.","journal-title":"Lancet Neurol"},{"issue":"2","key":"15909_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ana.20899","volume":"60","author":"KJ Bough","year":"2006","unstructured":"Bough KJ, Wetherington J, Hassel B, Pare JF, Gawryluk JW, Greene JG, et al. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol. 2006;60(2):223\u201335.","journal-title":"Ann Neurol"},{"issue":"3","key":"15909_CR14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/jnc.12646","volume":"129","author":"SD Hughes","year":"2014","unstructured":"Hughes SD, Kanabus M, Anderson G, Hargreaves IP, Rutherford T, O\u2019Donnell M, et al. The ketogenic diet component decanoic acid increases mitochondrial citrate synthase and complex I activity in neuronal cells. J Neurochem. 2014;129(3):426\u201333.","journal-title":"J Neurochem"},{"issue":"36","key":"15909_CR15","doi-asserted-by":"publisher","first-page":"e2321874121","DOI":"10.1073\/pnas.2321874121","volume":"121","author":"E Pain","year":"2024","unstructured":"Pain E, Snowden S, Oddy J, Shinhmar S, Alhammad YMA, King JS, et al. Pharmacological inhibition of ENT1 enhances the impact of specific dietary fats on energy metabolism gene expression. Proc Natl Acad Sci U S A. 2024;121(36):e2321874121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 2","key":"15909_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/brain\/awv325","volume":"139","author":"P Chang","year":"2016","unstructured":"Chang P, Augustin K, Boddum K, Williams S, Sun M, Terschak JA, et al. Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain. 2016;139(Pt 2):431\u201343.","journal-title":"Brain"},{"issue":"38","key":"15909_CR17","doi-asserted-by":"publisher","first-page":"23617","DOI":"10.1073\/pnas.2008980117","volume":"117","author":"EC Warren","year":"2020","unstructured":"Warren EC, Dooves S, Lugara E, Damstra-Oddy J, Schaf J, Heine VM, et al. Decanoic acid inhibits mTORC1 activity independent of glucose and insulin signaling. Proc Natl Acad Sci U S A. 2020;117(38):23617\u201325.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"15909_CR18","doi-asserted-by":"publisher","first-page":"fcab160","DOI":"10.1093\/braincomms\/fcab160","volume":"3","author":"NE Schoeler","year":"2021","unstructured":"Schoeler NE, Orford M, Vivekananda U, Simpson Z, Van de Bor B, Smith H, et al. K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy. Brain Commun. 2021;3(4):fcab160.","journal-title":"Brain Commun"},{"key":"15909_CR19","doi-asserted-by":"publisher","first-page":"115651","DOI":"10.1016\/j.carbpol.2019.115651","volume":"230","author":"LEA Young","year":"2020","unstructured":"Young LEA, Brizzee CO, Macedo JKA, Murphy RD, Contreras CJ, DePaoli-Roach AA, et al. Accurate and sensitive quantitation of glucose and glucose phosphates derived from storage carbohydrates by mass spectrometry. Carbohydr Polym. 2020;230:115651.","journal-title":"Carbohydr Polym"},{"issue":"7","key":"15909_CR20","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.cmet.2021.05.003","volume":"33","author":"RC Sun","year":"2021","unstructured":"Sun RC, Young LEA, Bruntz RC, Markussen KH, Zhou Z, Conroy LR, et al. Brain glycogen serves as a critical glucosamine cache required for protein glycosylation. Cell Metab. 2021;33(7):1404\u201317. e1409.","journal-title":"Cell Metab"},{"key":"15909_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/0471142727.mb3004s114","volume":"114","author":"O Fiehn","year":"2016","unstructured":"Fiehn O. Metabolomics by Gas Chromatography-Mass Spectrometry: Combined Targeted and Untargeted Profiling. Curr Protoc Mol Biol. 2016;114:30. 34 31\u2009\u2013\u200930 34 32.","journal-title":"Curr Protoc Mol Biol"},{"issue":"D1","key":"15909_CR22","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol Y, Bandla C, Kundu DJ, Kamatchinathan S, Bai J, Hewapathirana S, et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 2025;53(D1):D543\u201353.","journal-title":"Nucleic Acids Res"},{"key":"15909_CR23","doi-asserted-by":"publisher","first-page":"988872","DOI":"10.3389\/fonc.2022.988872","volume":"12","author":"S Parik","year":"2022","unstructured":"Parik S, Fernandez-Garcia J, Lodi F, De Vlaminck K, Derweduwe M, De Vleeschouwer S, et al. GBM tumors are heterogeneous in their fatty acid metabolism and modulating fatty acid metabolism sensitizes cancer cells derived from recurring GBM tumors to temozolomide. Front Oncol. 2022;12:988872.","journal-title":"Front Oncol"},{"issue":"1","key":"15909_CR24","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/s41467-022-29137-3","volume":"13","author":"N Jiang","year":"2022","unstructured":"Jiang N, Xie B, Xiao W, Fan M, Xu S, Duan Y, et al. Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion. Nat Commun. 2022;13(1):1511.","journal-title":"Nat Commun"},{"key":"15909_CR25","doi-asserted-by":"publisher","first-page":"2630565","DOI":"10.1155\/2018\/2630565","volume":"2018","author":"CJDC Harvey","year":"2018","unstructured":"Harvey CJDC, Schofield GM, Williden M, McQuillan JA. The Effect of Medium Chain Triglycerides on Time to Nutritional Ketosis and Symptoms of Keto-Induction in Healthy Adults: A Randomised Controlled Clinical Trial. J Nutr Metab. 2018;2018:2630565.","journal-title":"J Nutr Metab"},{"key":"15909_CR26","doi-asserted-by":"publisher","first-page":"633210","DOI":"10.3389\/fonc.2021.633210","volume":"11","author":"KJ McKelvey","year":"2021","unstructured":"McKelvey KJ, Wilson EB, Short S, Melcher AA, Biggs M, Diakos CI, et al. Glycolysis and fatty acid oxidation inhibition improves survival in glioblastoma. Front Oncol. 2021;11:633210.","journal-title":"Front Oncol"},{"key":"15909_CR27","doi-asserted-by":"publisher","unstructured":"Martins F, van der Kellen D, Goncalves LG, Serpa J. Metabolic profiles point out metabolic pathways pivotal in two glioblastoma (GBM) cell lines, U251 and U-87MG. Biomedicines. 2023;11(7). https:\/\/doi.org\/10.3390\/biomedicines11072041.","DOI":"10.3390\/biomedicines11072041"},{"issue":"3","key":"15909_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/epi4.12414","volume":"5","author":"J Klepper","year":"2020","unstructured":"Klepper J, Akman C, Armeno M, Auvin S, Cervenka M, Cross HJ, et al. Glut1 Deficiency Syndrome (Glut1DS): State of the art in 2020 and recommendations of the international Glut1DS study group. Epilepsia Open. 2020;5(3):354\u201365.","journal-title":"Epilepsia Open"},{"issue":"7573","key":"15909_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nature14655","volume":"526","author":"D Deng","year":"2015","unstructured":"Deng D, Sun P, Yan C, Ke M, Jiang X, Xiong L, et al. Molecular basis of ligand recognition and transport by glucose transporters. Nature. 2015;526(7573):391\u20136.","journal-title":"Nature"},{"key":"15909_CR30","first-page":"597913","volume":"2008","author":"R Moreno-Sanchez","year":"2008","unstructured":"Moreno-Sanchez R, Saavedra E, Rodriguez-Enriquez S, Olin-Sandoval V. Metabolic control analysis: a tool for designing strategies to manipulate metabolic pathways. J Biomed Biotechnol. 2008;2008:597913.","journal-title":"J Biomed Biotechnol"},{"issue":"20","key":"15909_CR31","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1056\/NEJMoa1407778","volume":"371","author":"PM van Hasselt","year":"2014","unstructured":"van Hasselt PM, Ferdinandusse S, Monroe GR, Ruiter JP, Turkenburg M, Geerlings MJ, et al. Monocarboxylate transporter 1 deficiency and ketone utilization. N Engl J Med. 2014;371(20):1900\u20137.","journal-title":"N Engl J Med"},{"issue":"4","key":"15909_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cmet.2007.03.004","volume":"5","author":"SC Burgess","year":"2007","unstructured":"Burgess SC, He T, Yan Z, Lindner J, Sherry AD, Malloy CR, et al. Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. Cell Metab. 2007;5(4):313\u201320.","journal-title":"Cell Metab"},{"issue":"43","key":"15909_CR33","doi-asserted-by":"publisher","first-page":"30527","DOI":"10.1074\/jbc.274.43.30527","volume":"274","author":"BV Geisbrecht","year":"1999","unstructured":"Geisbrecht BV, Gould SJ. The human PICD gene encodes a cytoplasmic and peroxisomal NADP(+)-dependent isocitrate dehydrogenase. J Biol Chem. 1999;274(43):30527\u201333.","journal-title":"J Biol Chem"},{"issue":"3","key":"15909_CR34","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/brv.12140","volume":"90","author":"A Stincone","year":"2015","unstructured":"Stincone A, Prigione A, Cramer T, Wamelink MM, Campbell K, Cheung E, et al. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol Rev Camb Philos Soc. 2015;90(3):927\u201363.","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"1","key":"15909_CR35","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1186\/s12885-020-07472-2","volume":"20","author":"Y Meng","year":"2020","unstructured":"Meng Y, Hu X, Li S, Zeng X, Qiu L, Wei M, et al. miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1. BMC Cancer. 2020;20(1):1028.","journal-title":"BMC Cancer"},{"key":"15909_CR36","doi-asserted-by":"publisher","first-page":"1434118","DOI":"10.3389\/fimmu.2024.1434118","volume":"15","author":"Y Han","year":"2024","unstructured":"Han Y, Dong C, Hu M, Wang X, Wang G. Unlocking the adenosine receptor mechanism of the tumour immune microenvironment. Front Immunol. 2024;15:1434118.","journal-title":"Front Immunol"},{"issue":"8","key":"15909_CR37","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1073\/pnas.86.8.2663","volume":"86","author":"JA Hamilton","year":"1989","unstructured":"Hamilton JA. Medium-chain fatty acid binding to albumin and transfer to phospholipid bilayers. Proc Natl Acad Sci U S A. 1989;86(8):2663\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"15909_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12943-022-01496-x","volume":"21","author":"AM Hortal","year":"2022","unstructured":"Hortal AM, Oeste CL, Cifuentes C, Alcoceba M, Fernandez-Pisonero I, Clavain L, et al. Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia. Mol Cancer. 2022;21(1):35.","journal-title":"Mol Cancer"},{"issue":"1","key":"15909_CR39","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12943-024-02054-3","volume":"23","author":"C Cifuentes","year":"2024","unstructured":"Cifuentes C, Oeste CL, Fernandez-Pisonero I, Hortal AM, Garcia-Macias C, Hochart J, et al. Unmutated RRAS2 emerges as a key oncogene in post-partum-associated triple negative breast cancer. Mol Cancer. 2024;23(1):142.","journal-title":"Mol Cancer"},{"key":"15909_CR40","doi-asserted-by":"publisher","unstructured":"Valdez CN, Sanchez-Zuno GA, Bucala R, Tran TT. Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities. Int J Mol Sci. 2024;25(9). https:\/\/doi.org\/10.3390\/ijms25094849.","DOI":"10.3390\/ijms25094849"},{"key":"15909_CR41","doi-asserted-by":"publisher","first-page":"101907","DOI":"10.1016\/j.tranon.2024.101907","volume":"43","author":"C Van Berckelaer","year":"2024","unstructured":"Van Berckelaer C, Van Laere S, Lee S, Morse MA, Geradts J, Dirix L, et al. XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant. Transl Oncol. 2024;43:101907.","journal-title":"Transl Oncol"},{"issue":"2","key":"15909_CR42","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/1878-0261.12915","volume":"19","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Yue C, Krichevsky AM, Garkavtsev I. Repression of the stress granule protein G3BP2 inhibits immune checkpoint molecule PD-L1. Mol Oncol. 2021;19(2):558\u201371.","journal-title":"Mol Oncol"},{"issue":"8","key":"15909_CR43","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1021\/cr000110o","volume":"101","author":"A Ali","year":"2001","unstructured":"Ali A, Hoeflich KP, Woodgett JR. Glycogen synthase kinase-3: properties, functions, and regulation. Chem Rev. 2001;101(8):2527\u201340.","journal-title":"Chem Rev"},{"issue":"1","key":"15909_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12964-022-00825-3","volume":"20","author":"X Cao","year":"2022","unstructured":"Cao X, Wu W, Wang D, Sun W, Lai S. Glycogen synthase kinase GSK3alpha promotes tumorigenesis by activating HIF1\/VEGFA signaling pathway in NSCLC tumor. Cell Commun Signal. 2022;20(1):32.","journal-title":"Cell Commun Signal"},{"key":"15909_CR45","doi-asserted-by":"publisher","first-page":"104270","DOI":"10.1016\/j.phrs.2019.104270","volume":"145","author":"A Alwhaibi","year":"2019","unstructured":"Alwhaibi A, Verma A, Adil MS, Somanath PR. The unconventional role of Akt1 in the advanced cancers and in diabetes-promoted carcinogenesis. Pharmacol Res. 2019;145:104270.","journal-title":"Pharmacol Res"},{"key":"15909_CR46","doi-asserted-by":"publisher","first-page":"972913","DOI":"10.1155\/2013\/972913","volume":"2013","author":"N Traverso","year":"2013","unstructured":"Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro AL, Pronzato MA, et al. Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev. 2013;2013:972913.","journal-title":"Oxid Med Cell Longev"},{"key":"15909_CR47","doi-asserted-by":"publisher","unstructured":"Gaca-Tabaszewska M, Bogusiewicz J, Bojko B. Metabolomic and Lipidomic Profiling of Gliomas-A New Direction in Personalized Therapies. Cancers (Basel). 2022;14(20). https:\/\/doi.org\/10.3390\/cancers14205041.","DOI":"10.3390\/cancers14205041"},{"issue":"4","key":"15909_CR48","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/BF00182178","volume":"36","author":"SL Miller","year":"1993","unstructured":"Miller SL, Schlesinger G. Prebiotic syntheses of vitamin coenzymes: II. Pantoic acid, pantothenic acid, and the composition of coenzyme A. J Mol Evol. 1993;36(4):308\u201314.","journal-title":"J Mol Evol"},{"issue":"6","key":"15909_CR49","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cmet.2015.05.014","volume":"21","author":"F Pietrocola","year":"2015","unstructured":"Pietrocola F, Galluzzi L, Bravo-San Pedro JM, Madeo F, Kroemer G. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metab. 2015;21(6):805\u201321.","journal-title":"Cell Metab"},{"issue":"2","key":"15909_CR50","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.celrep.2019.03.036","volume":"27","author":"T Nguyen","year":"2019","unstructured":"Nguyen T, Kirsch BJ, Asaka R, Nabi K, Quinones A, Tan J, et al. Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer. Cell Rep. 2019;27(2):491\u2013501. e496.","journal-title":"Cell Rep"},{"key":"15909_CR51","doi-asserted-by":"publisher","first-page":"103051","DOI":"10.1016\/j.copbio.2023.103051","volume":"85","author":"N Krause","year":"2024","unstructured":"Krause N, Wegner A. N-acetyl-aspartate metabolism at the interface of cancer, immunity, and neurodegeneration. Curr Opin Biotechnol. 2024;85:103051.","journal-title":"Curr Opin Biotechnol"},{"key":"15909_CR52","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.pnpbp.2014.10.013","volume":"57","author":"P Wlaz","year":"2015","unstructured":"Wlaz P, Socala K, Nieoczym D, Zarnowski T, Zarnowska I, Czuczwar SJ, et al. Acute anticonvulsant effects of capric acid in seizure tests in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2015;57:110\u20136.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"8","key":"15909_CR53","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/epi.13833","volume":"58","author":"A Khabbush","year":"2017","unstructured":"Khabbush A, Orford M, Tsai YC, Rutherford T, O\u2019Donnell M, Eaton S, et al. Neuronal decanoic acid oxidation is markedly lower than that of octanoic acid: a mechanistic insight into the medium-chain triglyceride ketogenic diet. Epilepsia. 2017;58(8):1423\u20139.","journal-title":"Epilepsia"},{"issue":"3191","key":"15909_CR54","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309\u201314.","journal-title":"Science"},{"issue":"6","key":"15909_CR55","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","volume":"14","author":"M Belanger","year":"2011","unstructured":"Belanger M, Allaman I, Magistretti PJ. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 2011;14(6):724\u201338.","journal-title":"Cell Metab"},{"issue":"2 Pt A","key":"15909_CR56","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.canlet.2014.04.001","volume":"356","author":"J Lu","year":"2015","unstructured":"Lu J, Tan M, Cai Q. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett. 2015;356(2 Pt A):156\u201364.","journal-title":"Cancer Lett"},{"issue":"7","key":"15909_CR57","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/17460441.2019.1613370","volume":"14","author":"N Albadari","year":"2019","unstructured":"Albadari N, Deng S, Li W. The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy. Expert Opin Drug Discov. 2019;14(7):667\u201382.","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"15909_CR58","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1743-7075-10-47","volume":"10","author":"HT Chang","year":"2013","unstructured":"Chang HT, Olson LK, Schwartz KA. Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy. Nutr Metab (Lond). 2013;10(1):47.","journal-title":"Nutr Metab (Lond)"},{"issue":"4","key":"15909_CR59","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/jnr.490180407","volume":"18","author":"J Edmond","year":"1987","unstructured":"Edmond J, Robbins RA, Bergstrom JD, Cole RA, de Vellis J. Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture. J Neurosci Res. 1987;18(4):551\u201361.","journal-title":"J Neurosci Res"},{"issue":"3","key":"15909_CR60","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10545-016-9930-4","volume":"39","author":"M Kanabus","year":"2016","unstructured":"Kanabus M, Fassone E, Hughes SD, Bilooei SF, Rutherford T, Donnell MO, et al. The pleiotropic effects of decanoic acid treatment on mitochondrial function in fibroblasts from patients with complex I deficient Leigh syndrome. J Inherit Metab Dis. 2016;39(3):415\u201326.","journal-title":"J Inherit Metab Dis"},{"key":"15909_CR61","doi-asserted-by":"publisher","unstructured":"Rao SI, Wade A, Sihna U, Shaywitz A, Virani S, Gretler DD, et al. The pharmacokinetics of orally administered calcium pantothenate in healthy adults. J Vitamins Minerals. 2021;3(01). https:\/\/doi.org\/10.29011\/JVM-106.100006.","DOI":"10.29011\/JVM-106.100006"},{"issue":"13","key":"15909_CR62","doi-asserted-by":"publisher","first-page":"7501","DOI":"10.1074\/jbc.273.13.7501","volume":"273","author":"PD Prasad","year":"1998","unstructured":"Prasad PD, Wang H, Kekuda R, Fujita T, Fei YJ, Devoe LD, et al. Cloning and functional expression of a cDNA encoding a mammalian sodium-dependent vitamin transporter mediating the uptake of pantothenate, biotin, and lipoate. J Biol Chem. 1998;273(13):7501\u20136.","journal-title":"J Biol Chem"},{"issue":"7","key":"15909_CR63","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2174\/1568026611313070006","volume":"13","author":"SR Chirapu","year":"2013","unstructured":"Chirapu SR, Rotter CJ, Miller EL, Varma MV, Dow RL, Finn MG. High specificity in response of the sodium-dependent multivitamin transporter to derivatives of pantothenic acid. Curr Top Med Chem. 2013;13(7):837\u201342.","journal-title":"Curr Top Med Chem"},{"issue":"7","key":"15909_CR64","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1158\/2159-8290.CD-19-0959","volume":"10","author":"SJ Parker","year":"2020","unstructured":"Parker SJ, Amendola CR, Hollinshead KER, Yu Q, Yamamoto K, Encarnacion-Rosado J, et al. Selective alanine transporter utilization creates a targetable metabolic niche in pancreatic cancer. Cancer Discov. 2020;10(7):1018\u201337.","journal-title":"Cancer Discov"},{"issue":"8","key":"15909_CR65","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/jn\/nxy119","volume":"148","author":"CW Cohen","year":"2018","unstructured":"Cohen CW, Fontaine KR, Arend RC, Alvarez RD, Leath CA III, Huh WK, et al. Gower BA: a ketogenic diet reduces central obesity and serum insulin in women with ovarian or endometrial cancer. J Nutr. 2018;148(8):1253\u201360.","journal-title":"J Nutr"},{"issue":"1","key":"15909_CR66","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1743-7075-8-54","volume":"8","author":"M Schmidt","year":"2011","unstructured":"Schmidt M, Pfetzer N, Schwab M, Strauss I, Kammerer U. Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial. Nutr Metab (Lond). 2011;8(1):54.","journal-title":"Nutr Metab (Lond)"},{"key":"15909_CR67","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fendo.2015.00077","volume":"6","author":"LW Bowers","year":"2015","unstructured":"Bowers LW, Rossi EL, O\u2019Flanagan CH, deGraffenried LA, Hursting SD. The Role of the Insulin\/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link. Front Endocrinol (Lausanne). 2015;6:77.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"15909_CR68","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1111\/j.1528-1167.2011.02981.x","volume":"52","author":"SS McDaniel","year":"2011","unstructured":"McDaniel SS, Rensing NR, Thio LL, Yamada KA, Wong M. The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia. 2011;52(3):e7\u201311.","journal-title":"Epilepsia"},{"issue":"1","key":"15909_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nut.2014.06.011","volume":"31","author":"RD Feinman","year":"2015","unstructured":"Feinman RD, Pogozelski WK, Astrup A, Bernstein RK, Fine EJ, Westman EC, et al. Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition. 2015;31(1):1\u201313.","journal-title":"Nutrition"},{"issue":"1","key":"15909_CR70","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.1038\/s41598-021-85523-9","volume":"11","author":"J Mett","year":"2021","unstructured":"Mett J, Muller U. The medium-chain fatty acid decanoic acid reduces oxidative stress levels in neuroblastoma cells. Sci Rep. 2021;11(1):6135.","journal-title":"Sci Rep"},{"key":"15909_CR71","doi-asserted-by":"publisher","unstructured":"Yang MH, Lee M, Deivasigamani A, Le DD, Mohan CD, Hui KM, et al. Decanoic acid exerts its anti-tumor effects via targeting c-Met signaling cascades in hepatocellular carcinoma model. Cancers (Basel). 2023;15(19). https:\/\/doi.org\/10.3390\/cancers15194681.","DOI":"10.3390\/cancers15194681"},{"issue":"12","key":"15909_CR72","doi-asserted-by":"publisher","first-page":"833","DOI":"10.5483\/BMBRep.2008.41.12.833","volume":"41","author":"WK You","year":"2008","unstructured":"You WK, McDonald DM. The hepatocyte growth factor\/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis. BMB Rep. 2008;41(12):833\u20139.","journal-title":"BMB Rep"},{"issue":"7546","key":"15909_CR73","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nature14362","volume":"520","author":"S Schoors","year":"2015","unstructured":"Schoors S, Bruning U, Missiaen R, Queiroz KC, Borgers G, Elia I, et al. Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature. 2015;520(7546):192\u20137.","journal-title":"Nature"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15909-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15909-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15909-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:33:29Z","timestamp":1781645609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15909-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15909"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15909-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"T.R. is employed by Vitaflo International. Related intellectual property is partially attributed to R.S.B.W.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"621"}}